Events

Physiomics plc (AIM: PYC), a leading mathematical modelling company supporting oncology drug development, is pleased to announce that it is hosting a free webinar on the Mathematical Modelling in the age of Project Optimus on 30th March 2023 from 3pm - 4pm (BST).   Who should attend? Anyone with an interest in getting approval for first in human and subsequent clinical studies. You might be an investor,...

Physiomics plc (AIM: PYC), a leading mathematical modelling company supporting oncology drug development, is pleased to announce that it is attending the AACR 2023 conference at the Orange County Convention Center, Orlando, FL, USA on 14-19 April 2023.   Physiomics Head of Business Development, Hayley Close, will be attending the conference. Companies interested in meeting with Physiomics should email Hayley directly at hclose@physiomics.co.uk.   Enquiries:   Physiomics plc                                                   Dr Jim Millen,...

Physiomics plc (AIM: PYC), a leading mathematical modelling company supporting oncology drug development, is pleased to announce that it is attending the BIO-Europe Spring digital conference on 28-30 March 2023.   Physiomics Head of Business Development, Hayley Close, will be attending the conference digitally. Companies interested in meeting with Physiomics should email Hayley directly at hclose@physiomics.co.uk.   Enquiries:   Physiomics plc                                                   Dr Jim Millen, CEO +44 (0)1865 784 980   Hybridan LLP (broker) Claire Louise...